Lotus Pharmaceutical · Tashkent · Tashkent

Zepzelca (lurbinectedin)

Licensed oncology product for extensive-stage small cell lung cancer. Approved by TFDA for first-line maintenance therapy in combination with immunotherapy.

Zepzelca (lurbinectedin) is manufactured by Lotus Pharmaceutical in Tashkent, Tashkent. Buying for your business? You can request it via us — we get quotes, inspect before shipment and ship to any destination.

Catalogue Work via us